Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.

A groundbreaking study from Stanford University has revealed that CAR-T cell therapy, a promising cancer treatment, may cause mild cognitive side effects such as forgetfulness and difficulty focusing— ...

Apple’s new BCI Human Interface Device protocol marks the creation of a new input category powered by thought, enabling hands ...

Stork bite — a reddish discoloration or birthmark on the skin of a newborn baby, typically found on the back of the head or ...

The Salk Institute study, published in Frontiers in Aging Neuroscience, is an exciting step forward in understanding how ...

After treatment with CAR-T cells - immune cells engineered to attack cancer - patients sometimes tell their doctors they feel like they have "brain fog," or forgetfulness and difficulty concentrating.

It's true that many of the illnesses related to aging have components over which we have no control. But doctors and ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

Lecanemab and donanemab (Kisunla), another anti-amyloid treatment, won approval based on evidence that they slowed cognitive ...

Obstructive sleep apnea (OSA), commonly associated with cardiovascular and metabolic diseases, also plays a significant but ...